FDA granted Orphan Drug designation to the hospital for Trappsol hydroxypropyl-beta-cyclodextrin (HPBCD) to treat Niemann-Pick type C disease. Children's Hospital & Research Center , Oakland, Calif. Product: Trappsol hydroxypropyl-beta-cyclodextrin ( HPBCD ) Business: Metabolic WIR Staff...

The hospital granted BIOV an option to exclusively license a vaccine against Neisseria meningitidis serogroup B. If BIOV exercises its option, the hospital will receive a license fee and potential milestones and royalties. Also, BIOV...